Darren Woodside, Ph.D., is the Vice President for Research and Director of the Flow Cytometry and Imaging Core at the Texas Heart Institute. Show full bio
Dr. Woodside’s research centers around the role that cell adhesion plays in cardiovascular and autoimmune diseases, and the development of novel means to identify and treat these diseases. Prior to assuming the position of Vice President, he served as Associate Director of the Molecular Cardiology Research Laboratories at THI and Associate Director of Drug Discovery at Encysive Pharmaceuticals. He was awarded his Ph.D. from the University of Texas MD Anderson Cancer Center’s Department of Immunology and was a post-doctoral fellow at The Scripps Research Institute.
He has authored numerous publications, served on Editorial Review Boards, and currently chairs the NIH Innovative Immunology Study Section.
Queen's University at Kingston
University of Texas MD Anderson Cancer Center, Graduate School of Biomedical Sciences
The Scripps Research Institute
Technology co-invented by scientists at the Texas Heart Institute and 7 Hills Pharma received broad patent protection from the U.S....
Texas Heart Institute & 7 Hills Pharma awarded a $1.9 million grant from National Heart Lung Blood Institute to improve stem cell transplantation
HOUSTON, TX (June 11, 2020) —The Texas Heart Institute and 7 Hills Pharma (7 Hills) received a $1.9 million, Phase...
Rice University partnered with the Texas Heart Institute (THI) to define the body’s response to their injectable hydrogels that are...